All Outputs (2)

Patients' lived experiences of cytotoxic medications prescribed for the management of malignant solid tumours: a systematic review. [Protocol] (2018)
Other
BRINCAT, A., STEWART, D., WEIDMANN, A. and VELLA BONANNO, P. 2018. Patients' lived experiences of cytotoxic medications prescribed for the management of malignant solid tumours: a systematic review. [Protocol]. PROSPERO [online], item number CRD42016048457. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42016048457

The aim of the systematic review is to critically appraise, synthesise and present the available evidence of patients' lived experiences of cytotoxic medications prescribed for the management of malignant solid tumours. In relation to the patients ph... Read More about Patients' lived experiences of cytotoxic medications prescribed for the management of malignant solid tumours: a systematic review. [Protocol].

The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol] (2018)
Other
AL ADAWI, R., TONNA, A., STEWERT, D., RAYAN, C., ELEDRISI, M., and ABDELAZIZ, H. [2018]. The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol]. PROSPERO [online], item number CRD42018089862. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018089862

The aim of this research was to critically appraise, synthesise, and present the available evidence on the impact of pharmacists' input on the screening, prevention and management of metabolic syndrome (MetS). The specific aims were: 1) To determine... Read More about The impact of pharmacists’ input on the screening, management and prevention of metabolic syndrome. [Protocol].